David Rosen – ARQT history
- Issuer:
- ARCUTIS BIOTHERAPEUTICS INC
- Quarters tracked:
- 16 (Q3 2022 → Q2 2026)
- Current shares:
- 8,271,577
- Current value:
- $216.88M
- Peak shares:
- 10,966,672 (Q3 2024)
- Overall change:
- +1652%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 8,271,577 | $216.88M | $26.22 | 0 | 0% |
| Q1 2026 | 8,271,577 | $194.88M | $23.56 | 0 | 0% |
| Q4 2025 | 8,271,577 | $240.21M | $29.04 | -2,477,880 | -23% |
| Q3 2025 | 10,749,457 | $202.63M | $18.85 | 0 | 0% |
| Q2 2025 | 10,749,457 | $150.71M | $14.02 | -217,215 | -2% |
| Q1 2025 | 10,966,672 | $171.52M | $15.64 | 0 | 0% |
| Q4 2024 | 10,966,672 | $152.77M | $13.93 | 0 | 0% |
| Q3 2024 | 10,966,672 | $101.99M | $9.30 | +1,150,000 | +12% |
| Q2 2024 | 9,816,672 | $91.30M | $9.30 | +2,306,672 | +31% |
| Q1 2024 | 7,510,000 | $74.42M | $9.91 | +865,470 | +13% |
| Q4 2023 | 6,644,530 | $21.46M | $3.23 | +1,610,000 | +32% |
| Q3 2023 | 5,034,530 | $26.73M | $5.31 | +150,000 | +3% |
| Q2 2023 | 4,884,530 | $46.55M | $9.53 | +1,384,530 | +40% |
| Q1 2023 | 3,500,000 | $38.50M | $11.00 | +757,481 | +28% |
| Q4 2022 | 2,742,519 | $40.59M | $14.80 | +2,270,472 | +481% |
| Q3 2022 | 472,047 | $9.02M | $19.11 | — | NEW |